Your browser doesn't support javascript.
loading
Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells.
Byrgazov, Konstantin; Besse, Andrej; Kraus, Marianne; Slipicevic, Ana; Lehmann, Fredrik; Driessen, Christoph; Besse, Lenka.
Affiliation
  • Byrgazov K; Oncopeptides AB, Stockholm, Sweden.
  • Besse A; Experimental Oncology and Hematology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland.
  • Kraus M; Experimental Oncology and Hematology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland.
  • Slipicevic A; Oncopeptides AB, Stockholm, Sweden.
  • Lehmann F; Oncopeptides AB, Stockholm, Sweden.
  • Driessen C; Experimental Oncology and Hematology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland.
  • Besse L; Experimental Oncology and Hematology, Department of Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland.
Hemasphere ; 5(7): e602, 2021 Jul.
Article in En | MEDLINE | ID: mdl-34136753
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2021 Type: Article Affiliation country: Sweden
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2021 Type: Article Affiliation country: Sweden